VRUS
Pharmasset Inc
Clinical-stage pharmaceutical company developing oral therapeutics for viral infections, notably hepatitis C (HCV)
CUSIP: 71715N106HealthcareUS1 holder
Pharmasset Inc
Clinical-stage pharmaceutical company developing oral therapeutics for viral infections, notably hepatitis C (HCV)
No insider transactions reported in the last 3 years. Look across all recorded history →